Return to study ST003036 main page
MB Sample ID: SA328849
Local Sample ID: | QC_5 |
Subject ID: | SU003150 |
Subject Type: | Bacteria |
Subject Species: | Pseudomonas aeruginosa |
Taxonomy ID: | 287 |
Genotype Strain: | CW41 |
Age Or Age Range: | NA |
Weight Or Weight Range: | NA |
Gender: | Not applicable |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR003159 |
Treatment Summary: | Ceftolozane-tazobactam was administered to simulate steady-state concentrations of ceftolozane predicted to occur in the epithelial lining fluid of the lung in patients with CF, following daily doses of 3 g/1.5 g and 6 g/3 g via continuous infusion (10.6 and 21.3 mg/L, respectively) (21-23). Total bacterial populations were quantified on antibiotic-free CAMHA, and resistant subpopulations on CAMHA containing ceftolozane-tazobactam (12 and 20 mg/L). |
Treatment Compound: | Ceftolozane-tazobactam |
Treatment Dose: | 3 g and 6 g |
Treatment Dosevolume: | 10.6 and 21.3 mg/L |